AXQ CAPITAL, LP

Position in GRFS — Grifols SA

CIK 1916908 JERSEY CITY, NJ

Position in GRFS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$194,757

New position

Shares Held

24,284

first reported quarter

Ownership

0.009%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AXQ CAPITAL, LP holds $4,540,742 across 4 Drug Manufacturers - General names. GRFS ranks #3 (4.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,638	$2,426,353
2	BMY	Bristol Myers Squibb Co	30,117	$1,826,596
3	GRFS	Grifols SA This page	24,284	$194,757
4	OGN	Organon & Co.	15,532	$93,036

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$194,757	24,284	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.